Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,646 | -31,422 | -232,493 | -188,602 | -76,038 |
| Depreciation Amortization | 5,185 | 2,812 | 90,653 | 87,236 | 6,363 |
| Accounts receivable | 3,064 | 1,004 | -2,296 | -1,646 | -590 |
| Accounts payable and accrued liabilities | -1,648 | -537 | -1,995 | 2,401 | -791 |
| Other Working Capital | 939 | 5,300 | -14,770 | -8,519 | -9,597 |
| Other Operating Activity | -9,003 | -5,288 | 35,720 | 13,728 | 11,544 |
| Operating Cash Flow | $-49,109 | $-28,131 | $-125,181 | $-95,402 | $-69,109 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -103 | -26 | -1,691 | -946 | -839 |
| Net Acquisitions | N/A | N/A | 96 | 96 | 96 |
| Purchase Of Investment | -151,585 | -110,557 | -111,264 | -4,485 | N/A |
| Sale Of Investment | 227,905 | 158,169 | 137,017 | 84,866 | 46,879 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -32 |
| Investing Cash Flow | $76,217 | $47,586 | $24,158 | $79,531 | $46,104 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 18,000 | N/A | 80,000 | N/A | N/A |
| Debt Repayment | -62,473 | -36,677 | -9,047 | -34 | -22 |
| Common Stock Issued | 27,614 | 15,445 | 56,383 | 46,526 | 33,602 |
| Other Financing Activity | -6,737 | -386 | -13,521 | -1,161 | -837 |
| Financing Cash Flow | $-23,596 | $-21,618 | $113,815 | $45,331 | $32,743 |
| Exchange Rate Effect | -27 | -26 | 65 | 17 | 27 |
| Beginning Cash Position | 18,348 | 18,348 | 5,491 | 5,491 | 5,491 |
| End Cash Position | 21,833 | 16,159 | 18,348 | 34,968 | 15,256 |
| Net Cash Flow | $3,485 | $-2,189 | $12,857 | $29,477 | $9,765 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,109 | -28,131 | -125,181 | -95,402 | -69,109 |
| Capital Expenditure | -103 | -26 | -1,691 | -946 | -839 |
| Free Cash Flow | -49,212 | -28,157 | -126,872 | -96,348 | -69,948 |